ArticleGeneral thoracic and cardiovascular surgery cases2022
Left subsuperior segmentectomy for a patient with early-stage lung cancer: a case report.
Article in General thoracic and cardiovascular surgery cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe independent segment between the superior and basal segments is called the subsuperior segment (S*), which is rarely observed. We report a left S* segmentectomy in a patient with early-stage lung cancer. CASE PRESENTATION: A 72-year-old man presented with a history of hilar cholangiocarcinoma. A left lung ground-glass nodule was detected during follow-up examination. The tumor shadow was localized in the left S* according to the findings of the three-dimensional image analysis system (SYNAPSE VINCENT®) with computed tomography-based analysis. S* segmentectomy was successfully performed with a sufficient surgical margin. The operation time was 147 min, and there was a small amount of bleeding. The pathological diagnosis was invasive adenocarcinoma measuring 3 mm. The tumor was successfully removed with a sufficient surgical margin. The patient was discharged from the hospital 8 days after surgery without any complications.
conclusionsS* segmentectomy is not typically performed in patients with lung cancer due to insufficient surgical margins. However, S* segmentectomy is a viable option for selected patients with pulmonary metastasis or early-stage lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.